• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎患儿中()、、和基因单核苷酸多态性与严重症状之间的关联。 (注:原文括号处内容缺失)

Association Between Single-Nucleotide Polymorphisms in (), , and Genes with Severe Symptoms in Children Presenting COVID-19.

作者信息

Andrade Adriana Souza, Bentes Aline Almeida, Diniz Lilian Martins, Carvalho Silvia Hees, Kroon Erna Geessien, Campos Marco Antonio

机构信息

Instituto René Rachou/Fiocruz Minas, Belo Horizonte 30190-009, MG, Brazil.

Departamento de Pediatria, Universidade Federal de Minas Gerais, Belo Horizonte 30130-110, MG, Brazil.

出版信息

Viruses. 2024 Dec 30;17(1):35. doi: 10.3390/v17010035.

DOI:10.3390/v17010035
PMID:39861824
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11769468/
Abstract

The global number of COVID-19 deaths has reached 7 million, with 4% of these deaths occurring in children and adolescents. In Brazil, around 1500 children up to 11 years old died from the disease. The most common symptoms in children are respiratory, potentially progressing to severe illnesses, such as severe acute respiratory syndrome (SARS) and MIS-C. Studies indicate that comorbidities and genetic factors, such as polymorphisms in immune response genes, can influence the severity of COVID-19. This study investigates the occurrence of single-nucleotide polymorphisms (SNPs) in innate immune response genes in children with COVID-19. Seventy-three samples were analyzed from children under 13 years old hospitalized at João Paulo II Children's Hospital due to COVID-19. The evaluated SNPs were (rs3764879), (rs2407992), (rs179008), (rs3775291), (rs8177374), and (rs1024611), considering four categories of severity: mild, moderate, severe, and critical COVID-19. To identify the SNPs, PCR and sequencing were performed. The frequencies of the SNPs obtained were not discrepant when compared to the frequencies described in the Global ALFA, Global 1000 Genomes, Global gnomAD, American 1000 Genomes, and American gnomAD databases, except for the SNP in TLR7. Comparing severe and critical cases to mild and moderate cases, we found a higher relative risk associated with mutations in , , , and ( < 0.05). No association was found for SNPs in and . Our analyses suggest an association between SNPs in innate immune response genes and severity of symptoms in children with COVID-19 (or SARS-CoV-2 infected children).

摘要

全球新冠死亡病例数已达700万,其中4%的死亡病例发生在儿童和青少年中。在巴西,约1500名11岁以下儿童死于该疾病。儿童中最常见的症状是呼吸道症状,可能进展为严重疾病,如严重急性呼吸综合征(SARS)和儿童多系统炎症综合征(MIS-C)。研究表明,合并症和遗传因素,如免疫反应基因中的多态性,可影响新冠的严重程度。本研究调查新冠儿童先天免疫反应基因中单核苷酸多态性(SNP)的发生情况。对因新冠在若昂·保罗二世儿童医院住院的13岁以下儿童的73份样本进行了分析。考虑到新冠的轻度、中度、重度和危重症四类严重程度,评估的SNP有(rs3764879)、(rs2407992)、(rs179008)、(rs3775291)、(rs8177374)和(rs1024611)。为鉴定SNP,进行了聚合酶链反应(PCR)和测序。与全球ALFA、全球千人基因组、全球基因组聚集数据库(gnomAD)、美国千人基因组和美国gnomAD数据库中描述的频率相比,除了Toll样受体7(TLR7)中的SNP外,获得的SNP频率并无差异。将重症和危重症病例与轻症和中症病例进行比较,我们发现与(基因名未给出)、(基因名未给出)、(基因名未给出)和(基因名未给出)中的突变相关的相对风险更高(P<0.05)。未发现(基因名未给出)和(基因名未给出)中的SNP存在关联。我们的分析表明,先天免疫反应基因中的SNP与新冠儿童(或感染新冠病毒的儿童)的症状严重程度之间存在关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e08/11769468/80da482b690b/viruses-17-00035-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e08/11769468/dc614ced99fa/viruses-17-00035-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e08/11769468/e9c490e162d7/viruses-17-00035-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e08/11769468/a6e9aa59e1b7/viruses-17-00035-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e08/11769468/1f530dc81d47/viruses-17-00035-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e08/11769468/56f4a7d6f904/viruses-17-00035-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e08/11769468/80da482b690b/viruses-17-00035-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e08/11769468/dc614ced99fa/viruses-17-00035-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e08/11769468/e9c490e162d7/viruses-17-00035-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e08/11769468/a6e9aa59e1b7/viruses-17-00035-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e08/11769468/1f530dc81d47/viruses-17-00035-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e08/11769468/56f4a7d6f904/viruses-17-00035-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e08/11769468/80da482b690b/viruses-17-00035-g006.jpg

相似文献

1
Association Between Single-Nucleotide Polymorphisms in (), , and Genes with Severe Symptoms in Children Presenting COVID-19.新型冠状病毒肺炎患儿中()、、和基因单核苷酸多态性与严重症状之间的关联。 (注:原文括号处内容缺失)
Viruses. 2024 Dec 30;17(1):35. doi: 10.3390/v17010035.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
3
From Rare to Common: Genetic Insights into TLR7 Variants in a Multicentric Spanish Study on COVID-19 Severity.从罕见到常见:西班牙一项关于 COVID-19 严重程度的多中心研究中 TLR7 变体的遗传学见解
J Clin Immunol. 2025 May 27;45(1):100. doi: 10.1007/s10875-025-01892-0.
4
Physical interventions to interrupt or reduce the spread of respiratory viruses.物理干预措施以阻断或减少呼吸道病毒的传播。
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.
5
Human genetic and immunological determinants of SARS-CoV-2 infection and multisystem inflammatory syndrome in children.儿童感染严重急性呼吸综合征冠状病毒2及多系统炎症综合征的人类遗传和免疫决定因素。
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxae062.
6
Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings.工作场所干预措施以降低医疗机构外 SARS-CoV-2 感染的风险。
Cochrane Database Syst Rev. 2022 May 6;5(5):CD015112. doi: 10.1002/14651858.CD015112.pub2.
7
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.用于治疗 COVID-19 的 SARS-CoV-2 中和单克隆抗体。
Cochrane Database Syst Rev. 2021 Sep 2;9(9):CD013825. doi: 10.1002/14651858.CD013825.pub2.
8
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.奈玛特韦片/利托那韦片组合包装用于 COVID-19 的预防和治疗。
Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD015395. doi: 10.1002/14651858.CD015395.pub2.
9
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
10
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.

引用本文的文献

1
The X-Linked rs179008 T Allele Is Associated with an Increased Risk of Severe Multisystem Inflammatory Syndrome in Children/Kawasaki-like Syndrome in SARS-CoV-2-Infected Boys.X连锁的rs179008 T等位基因与SARS-CoV-2感染男孩发生儿童严重多系统炎症综合征/川崎样综合征的风险增加相关。
Int J Mol Sci. 2025 Sep 1;26(17):8491. doi: 10.3390/ijms26178491.

本文引用的文献

1
rs1024611 Polymorphism, MCP-1 Concentrations, and Premature Coronary Artery Disease: Results of the Genetics of Atherosclerotic Disease (GEA) Mexican Study.rs1024611多态性、单核细胞趋化蛋白-1浓度与早发冠状动脉疾病:动脉粥样硬化疾病遗传学(GEA)墨西哥研究结果
Biomedicines. 2024 Jun 11;12(6):1292. doi: 10.3390/biomedicines12061292.
2
The Effect of Age and Comorbidities: Children vs. Adults in Their Response to SARS-CoV-2 Infection.年龄和合并症的影响:儿童与成人对 SARS-CoV-2 感染的反应。
Viruses. 2024 May 17;16(5):801. doi: 10.3390/v16050801.
3
Decoding Toll-like receptors: Recent insights and perspectives in innate immunity.
解析 Toll 样受体:固有免疫中的最新见解和展望。
Immunity. 2024 Apr 9;57(4):649-673. doi: 10.1016/j.immuni.2024.03.004.
4
Impact of Toll-Like Receptors (TLRs) and TLR Signaling Proteins in Trigeminal Ganglia Impairing Herpes Simplex Virus 1 (HSV-1) Progression to Encephalitis: Insights from Mouse Models.Toll 样受体(TLRs)及其信号蛋白在三叉神经节中对单纯疱疹病毒 1(HSV-1)向脑炎进展的影响:来自小鼠模型的见解。
Front Biosci (Landmark Ed). 2024 Mar 14;29(3):102. doi: 10.31083/j.fbl2903102.
5
Severe pediatric COVID-19: a review from the clinical and immunopathophysiological perspectives.严重儿童 COVID-19:从临床和免疫病理生理学角度的综述。
World J Pediatr. 2024 Apr;20(4):307-324. doi: 10.1007/s12519-023-00790-y. Epub 2024 Feb 6.
6
Pediatric COVID-19: clinical and epidemiological data of 1303 cases in a general hospital in Brazil.儿科 COVID-19:巴西一家综合医院 1303 例病例的临床和流行病学数据。
Rev Paul Pediatr. 2023 Dec 22;42:e2023031. doi: 10.1590/1984-0462/2024/42/2023031. eCollection 2023.
7
COVID-19 among infants: key clinical features and remaining controversies.婴儿中的新型冠状病毒肺炎:关键临床特征及尚存的争议
Clin Exp Pediatr. 2024 Jan;67(1):1-16. doi: 10.3345/cep.2023.00794. Epub 2023 Nov 27.
8
The role of TLR7 agonists in modulating COVID-19 severity in subjects with loss-of-function TLR7 variants.TLR7 激动剂在功能丧失型 TLR7 变异体患者中调节 COVID-19 严重程度中的作用。
Sci Rep. 2023 Aug 11;13(1):13078. doi: 10.1038/s41598-023-40114-8.
9
SARS-CoV-2 Infection and COVID-19 in Children.儿童感染 SARS-CoV-2 病毒和 COVID-19 疾病。
Clin Chest Med. 2023 Jun;44(2):359-371. doi: 10.1016/j.ccm.2022.11.014. Epub 2022 Nov 22.
10
Association of COVID-19 with Comorbidities: An Update.新型冠状病毒肺炎与合并症的关联:最新进展
ACS Pharmacol Transl Sci. 2023 Feb 27;6(3):334-354. doi: 10.1021/acsptsci.2c00181. eCollection 2023 Mar 10.